IN the early phenothiazine literature the ataractic properties of Thorazine in the control of disturbed, hyperactive schizophrenics were described (Kurland, 1955; Hall and Dunlap, 1955; Lehmann, 1955). Kurland (1955) gives an excellent description of the powerful activity ofThorazineinthis sphere, namely the control of hyperkinesis and hostile, aggressive behaviour; however, he found that there was little basic change in delusional thought disorder other than to divorce the abnormal thinking from its affective attachment. It was noted that the clinical improvement was most dramatic when the affective component of the illness was most marked. Hall and Dunlap (1955) felt that there was significant reduc tion in delusional ideation but noted that the schizophrenic process was not affected by Thorazine medication.
IN the early phenothiazine literature the ataractic properties of Thorazine in the control of disturbed, hyperactive schizophrenics were described (Kurland, 1955; Hall and Dunlap, 1955; Lehmann, 1955) . Kurland (1955) gives an excellent description of the powerful activity ofThorazineinthis sphere, namely the control of hyperkinesis and hostile, aggressive behaviour; however, he found that there was little basic change in delusional thought disorder other than to divorce the abnormal thinking from its affective attachment. It was noted that the clinical improvement was most dramatic when the affective component of the illness was most marked. Hall and Dunlap (1955) felt that there was significant reduc tion in delusional ideation but noted that the schizophrenic process was not affected by Thorazine medication.
With Compazine (Stemetil) stress was laid on different spheres of thera peutic activity, namely in the control of abnormal thought content and in influencing psychomotor activity. Compazine was reported as having active therapeutic properties in the amelioration of delusional ideation and hallucina tions (Mime and Berliner, 1958; Denham, 1958; Winkelman, 1959) . It would appear that Compazine has the dual ability to inhibit hyper-motility and to stimulate activity in the underactive patient. Freyhan (1958) found that it had a highly selective action in hyperkinetic syndromes, but other authors (Mime and Berliner, 1958 and Frierson, 1958) found it equally effective in counteracting * dull, withdrawn, apathetic, asocial and negativistic behaviour. In a comparative study of chlorpromazine (Thorazine-Largactil) and prochlorperazine (Com pazine-Stemetil), Dransfield (1958) found these drugs equally effective in con trolling hostile, aggressive, hyperactive behaviour; however, he found chlor promazine superior to prochiorperazine in counteracting apathy. It would appear that few toxic side-effects, for example bone marrow and liver toxicity (Wilcox, 1955) , have been recorded with Compazine and it also had the advantage of producing less somnolence than Thorazine. The predominant side-effects were extra-pyramidal in nature (Freyhan, 1958; Frierson, 1958; Wilcox, 1955; Pennington, 1959 ; Goldman, 1958 ; and Denber, 1958) . The extrapyramidal signs recorded are diverse, fine tremors, dystonic muscular spasms, akathesia and frank Parkinsonism. Goldman (1958) felt that extrapyramidal signs were an essential index of the therapeutic activity of the phenothiazine ; this view is supported by Denber (1958) Forrester, 1958) .
To summarize, it would appear that there are several basic trends in the evolution of the phenothiazines under review. Firstly, the drugs are becoming much more potent in much smaller dosages and secondly, they appear to be becoming much more specific in alleviating the primary thought, emotional and behavioural disorders in schizophrenia.
On the assumption that these drugs had a differential therapeutic effect in the alleviation of schizophrenic symptomatology, it was decided to conduct a double-blind drug trial in a small group of selected paranoid schizophrenics where the movement, of symptoms could be studied in some detail.
METHOD
In order to make the interpretation of results of this drug study more accurate and meaningful, the method of experimentation is described in some detail with special reference to selection of patients, physical environment and mode of drug administration. This descriptive method coincides to a large extent with the recommendations of a special committee for reporting drug studies. (U.S.PublicHealthReports, 1957).
I. SELECTION OF PATIENTS
An attempt was made to match the patients both historically and in clinical symptomatology.
The sample was selected according to diagnosis, sex, age, intelligence, lengthof illness and lengthof hospitalization. (SeeTable I.)
Eightfemalepatients were selected withthediagnosis of paranoidschizo phrenia; the diagnosis had been defined by case assessment at formal medical staff conference. The selection was made from a hospital service composed mainly of intermediate-stay patientsâ€"i.e., those who had failed to respond satisfactorily to the initial three months' intensive therapy following admission to hospital.
Before selection each case was reviewed in an attempt to obtain homo geneous clinical material which might reflect a similar disease process in each case. The main clinical criteria for selection were (1) Florid, easily elicited delusions of persecution, reference and influence. 
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z_@ @ flattening of affect, but could mobilize adequate affect especially when taxed regarding their delusional ideation). (5) All patients retained sufficient person ality integration to adjust satisfactorily to the social aspects of the mental hospital milieu and were able to take advantage of the facilities for occupational and recreational therapy.
From data on Table I , it can be seen that seven of the eight patients were in the fourth decade. Their ages ranged from 26â€"39years with a mean age of 32 years (S.D. 3 .7). The length of illness was assessed historically from the date of the first appearance of symptoms of morbid personality trends. The mean duration ofillness was 33 months with a minimum of 11 months and a maximum of 7 years. The mean duration of present stay in hospital was 8 . 1 months, with firstly, they would be unable to give a satisfactory commentary on subjective symptomatology and secondly, they would be unable to attempt the â€oe¿ Clyde
Mood Scaleâ€• on account of their intellectual deficit. It is of some importance to appreciate that these I.Q.'s were probably excellent reflections on the func tional intelligence of the patients at the time of testing, but do not accurately reflect the premorbid intellectual capacity of the individuals in the group. The data on family history was obtained by the retrospective suivey of the case records of the group and were not used for inclusive or exclusive criteria in the original sampling. However, it is interesting to note that all but one had a positive family history and four had a definitive family history of schizophrenia. Perlin and Russell Lee (1959) have recently indicated the possible importance of schizophrenic family history as a method of selection of a small group of schizophrenics for biological studies. The family history picture of the patients in this study, although purely fortuitous, may be highly relevant in the ultimate interpretation of results. The rather mixed nature of the familial neuropathies would appear to rule out a common genetically determined disease process, but might have some bearing on the malignancy of the pathological picture. Thus, the study might be interpreted as a comparative study of the effect of these drugs in the modification of descriptively similar symptoms, quantitatively, but not qualitatively, the same.
II. ENVIRONMENT
In recent papers more attention has been given to significant non-psycho pharmacological variables which might be of importance in research on the psychopharmacological drugs. Sherman (1959) classifies the important variables into drug variables, situational variables and person variables. In the present drug trial, no particular attempts were made to measure anything other than drug effect; however, it would appear pertinent to include a perfunctory description of the ward-setting and the salient features in the staff (aide) attitudes to psychiatric problems.
During the period of research the patients were congregated on one ward of nineteen beds. They were thus subjected to similar physical environment. The normal function of the ward was the treatment of acutely disturbed patients from other areas of the service. Thus, eight beds were used for research and eleven beds for the usual function of the ward. Being a disturbed ward, the ward facilities for recreational and occupational therapies were minimal, however, a television was available. On the ward, patients generally spent their time television-viewing or playing cards and other indoor games. During the experimental period the patients were granted maximum privileges as regards recreational and occupational therapies and parole within the limits of their mental conditions.
As a history from the aides on current patient social adjustment formed an essential part of the daily rating scale assessment, it might be relevant to point out that the aide staff, who were inured to dealing with disturbed patients, tended to be quite benign and sympathetic in their attitudes to â€oe¿ out-goingâ€• behaviour. This may have been an influential factor in biasing day-to-day rating scale assessment.
.
Ill. DRUG ADMINISTRATION
The experiment was conducted according to the double-blind method of study. Clinically, one physician was responsible for the administration of drugs and for the investigation and treatment of any side-effects which might occur. A second physician was responsible for the day-to-day assessment of psychiatric progress.
(a) Drugs
Three drugs, Thorazine (Largactil), Compazine (Stematil) and Stelazine and a placebo were used in the experimental plan. These drugs were each administered in two phases as regards dosage; one dosage was within the moderate range, the other dosage was considered to be sufficiently large to cause maximum movement in psychiatric symptomatology and perhaps also produce toxic side-effects. For dosage scale, see Table II . 
(b) Administration of Drugs
The patients received their medication thrice daily. (7.00 a.m., noon, 6.00 p.m.). The drugs and placebo were dispensed in identical pink capsules by Smith, Kline & French. The project was carried out over a period of nine weeks. The first week was preliminary to the administration of drugs. This was a period of observation when the patients were continued on their usual hospital medication. An attempt was made to establish a base-line of â€oe¿ averageâ€• behaviour and adjust ment to the ward environment. Scores from this week are not included in the analysis. Thereafter, the drug administration began. Drug and dosage was changed weekly on Saturday morning. During the eight weeks period of drug administration each patient had one week's administration of each drug in each of the dosage phases and two weeks placebo. (See Table Ill 
RESULTS
The relative effectiveness of the various drug treatment methods is shown in Figure 1 . On this graph the zero line is an overall mean of psychopathology as measured by the Sands-Malamud Scale. The height of the column reflects the degree of psychopathology observed. Individual weekly Sands-Malamud Scores are included in Table III. It is apparent that Stelazine and Compazine (Stemetil) are definitely superior to the placebo in control of symptoms. By an analysis of variance (Table IV) it is found that this superiority of Compazine and Stelazine to placebo could have occurred by chance less than one time in a hundred. There is some suggestion that the lower dose of Compazine, 10 Mg. t.i.d., is superior to 30 Mg. t.i.d. The data on this dosage from this experiment is, however, only suggestive and not conclusive.
Thorazine (Largactil) occupies an intermediate position, tending to be better than the placebo and not so effective as Stelazine and Compazine. The differences between Thorazine and placebo and Thorazine and the other two drugs did not fall within the usual 5 per cent. level of confidence of excluding chance, but this might occur with a larger sample.
A Chi Square analysis was done on the individual items of the Sands Malamud Scale comparing the placebo ratings with the 10 mg. t.i.d. Compazine ratings (the best results obtained). In this item analysis the placebo group in all instances displayed the greatest psychopathology. There was a ratherobvious arrangement with the behavioural and affective items tending to be highly different with Compazine and the â€oe¿ thoughtâ€• items essentially the same with Compazine and placebo. For example, the items Socialization, Responsivity and Speech were the top items displaying a difference between Compazine and placebo. These were followed by Affect, Feeling and Mood. By contrast, such items as Thought Content and Thought Processes were insignificantly different when the patients received Compazine.* We believe this result may in part be due to the fact that the Sands-Malamud Scale is probably better for detecting changes in behaviour and mood other than in thought processes. We would, however, like to call attention to the observation that in our experiment none of thedrugsappearedto have an appreciable effect on psychotic thinking. Our early expectations were, therefore, not substantiated, that is, when measured by the Sands-Malamud Rating Scale. One patient, as noted, had to be excluded from the statistical analysis because she developed paranoid ideas about the procedure, refused to take oral medication and thus did not complete the experiment. The Sands-Malamud Scale continued to be used, however, and the total pathology scores are included in Table III . In the sixth week, when her clinical state was at its worst, she was given intramuscular triflupromazine (Trilafon). Sufficient improvement ensued for her to be returned to project medication. This happened to be placebo, and there is some indication that her pathology score was rising again as the experi ment ended.
DISCUSSION
The omission of the results of the Clyde Mood Scale is to be noted. The test was successfully performed by these chronic schizophrenic patients (a find ing of some interest that they sorted the cards at all), but the results showed overall improvement with time, not differentiating one treatment from another.
It might be argued, of course, that these results mean that none of the medica tions were of any different effectiveness. But we believe that this is merely a good example of the degree to which results depend on the measuring instruments.
As this investigation proceeded, it became apparent that these patients highly correlated their giving a favourable picture of themselves with their hoped-for early release from the hospital. Thus, though â€oe¿ blindâ€•, the patients were not unbiased observers.* We believe, as stated, that this was due to the patients' assumption that a bland score meant early discharge. We conclude, therefore, that the Sands-Malamud Scores are more accurate. This criticism would not apply to the use of the Clyde Mood Scale in situations where secondary gain (or similar bias) was not in operation.
In calling attention to our favourable results with Compazine and Stelazine we would merely want to point out the obvious, namely that these results are highly pertinent for these conditions (diagnosis, type of patient, rating scale, etc.) and that generalizations must be made with caution.
On the other hand, probably the greatest significance of this particular undertaking is the demonstration that it is possible to draw specific conclusions from a small sample. This suggests an alternative method to large samples in drug studies. Even when one stacks the statistical cards against oneself by choosing a small sample, it is possible to draw conclusions of high statistical confidence with a combination of careful selection of a homogeneous group of patients, careful experimental design, potent medications and observations by an experienced observer on a scale with which he is familiar. 
